COVID-19 infection: a possible induction factor for development of autoimmune diseases?

Immunol Res. 2023 Aug;71(4):547-553. doi: 10.1007/s12026-023-09371-7. Epub 2023 Jun 14.

Abstract

Following the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the importance of investigation of the pathogenesis and immunological characteristics of COVID-19 became quite clear. Currently, there are reports indicating that COVID-19 is able to induce autoimmune responses. Abnormal immune reactions are a cornerstone in the pathogenicity of both conditions. Detection of autoantibodies in COVID-19 patients may suggest a link between COVID-19 and autoimmunity. In this study, we focused on the similarities and possible differences between COVID-19 and autoimmune disorders to explore the relationship between them. Comparing the pathogenicity of SARS-CoV-2 infection with autoimmune conditions revealed significant immunological properties of COVID-19 including the presence of several autoantibodies, autoimmunity-related cytokines, and cellular activities that could be useful in future clinical studies aiming at managing this pandemic.

Keywords: Autoimmune diseases; COVID-19; Cytokines; Pathogenesis.

Publication types

  • Review

MeSH terms

  • Autoantibodies
  • Autoimmune Diseases*
  • Autoimmunity
  • COVID-19*
  • Humans
  • SARS-CoV-2

Substances

  • Autoantibodies